gabapentin

Generic: gabapentin

Labeler: sun pharmaceutical industries, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler sun pharmaceutical industries, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 400 mg/1

Manufacturer
Sun Pharmaceutical Industries, Inc.

Identifiers & Regulatory

Product NDC 62756-139
Product ID 62756-139_aff50a15-df39-495f-a145-0ba59660eed8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077242
Listing Expiration 2026-12-31
Marketing Start 2022-02-01

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62756139
Hyphenated Format 62756-139

Supplemental Identifiers

UPC
0362756204010 0362756202016 0362756138025 0362756137028 0362756139022
UNII
6CW7F3G59X
NUI
N0000008486

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA077242 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 50 CAPSULE in 1 BOX, UNIT-DOSE (62756-139-01)
  • 100 CAPSULE in 1 BOTTLE (62756-139-02)
  • 100 CAPSULE in 1 BOTTLE (62756-139-03)
  • 1000 CAPSULE in 1 BOTTLE (62756-139-04)
  • 500 CAPSULE in 1 BOTTLE (62756-139-05)
source: ndc

Packages (5)

62756-139-01 50 CAPSULE in 1 BOX, UNIT-DOSE (62756-139-01) 62756-139-02 100 CAPSULE in 1 BOTTLE (62756-139-02) 62756-139-03 100 CAPSULE in 1 BOTTLE (62756-139-03) 62756-139-04 1000 CAPSULE in 1 BOTTLE (62756-139-04) 62756-139-05 500 CAPSULE in 1 BOTTLE (62756-139-05)

Ingredients (1)

gabapentin (400 mg/1)

Linked Drug Pages (1)

gabapentin ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "aff50a15-df39-495f-a145-0ba59660eed8", "openfda": {"nui": ["N0000008486"], "upc": ["0362756204010", "0362756202016", "0362756138025", "0362756137028", "0362756139022"], "unii": ["6CW7F3G59X"], "spl_set_id": ["c9a05f0c-b5f0-422c-9d67-6d0efc921a74"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "50 CAPSULE in 1 BOX, UNIT-DOSE (62756-139-01)", "package_ndc": "62756-139-01", "marketing_start_date": "20220201"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (62756-139-02)", "package_ndc": "62756-139-02", "marketing_start_date": "20220201"}, {"sample": false, "description": "100 CAPSULE in 1 BOTTLE (62756-139-03)", "package_ndc": "62756-139-03", "marketing_start_date": "20220201"}, {"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (62756-139-04)", "package_ndc": "62756-139-04", "marketing_start_date": "20220201"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (62756-139-05)", "package_ndc": "62756-139-05", "marketing_start_date": "20220201"}], "brand_name": "gabapentin", "product_id": "62756-139_aff50a15-df39-495f-a145-0ba59660eed8", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "62756-139", "generic_name": "gabapentin", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "400 mg/1"}], "application_number": "ANDA077242", "marketing_category": "ANDA", "marketing_start_date": "20220201", "listing_expiration_date": "20261231"}